Navigation Links
Transcept Pharmaceuticals to Present at Two Upcoming Conferences
Date:3/2/2009

ave difficulty returning to sleep. Intermezzo(R) Phase 3 clinical trials have been completed and, on September 30, 2008, Transcept submitted a New Drug Application (NDA) for Intermezzo(R) to the U.S. Food and Drug Administration (FDA) which was accepted for filing on December 15, 2008. The FDA has assigned a PDUFA date of July 30, 2009, to the Intermezzo(R) NDA.

For further information, please visit the company's website at: www.transcept.com.

Safe Harbor

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Transcept disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, statements relating to Intermezzo(R) being the first commercially available sleep aid in its target indication. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: positive results in clinical trials may not be sufficient to obtain FDA approval; physician or patient reluctance to use Intermezzo(R), if approved; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, or unexpected expenses incurred in connection with, obtaining regulatory approval, market acceptance and commercialization of Intermezzo(R).

    Contacts:

    Transcept Pharmaceuticals, Inc.
    Michael Gill
    Director of Communications
    (510) 215-3575
    mgill@transcept.com

    Th
'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
4. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
5. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
8. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
9. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
10. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 In May of 2010, after two ... life. In the wake of this tragedy, Ty’s parents Kirk ... that exposes the grim reality of bullying and its devastating ... Kirk and Laura to share their story and offer education ... to another family — a mission that took the Smalley ...
(Date:5/4/2015)... Now in its seventh year, the ... have made outstanding contributions to the company, to their ... acute and post-acute care settings. The five award categories ... the Year, Advanced Practice Clinician of the Year, Newcomer ... Year. Recipients are selected by IPC’s senior management team. ...
(Date:5/4/2015)... City, OK and Seattle, WA (PRWEB) May 04, 2015 ... announced the formation of a collaboration to facilitate development ... number of ophthalmic disorders that lead to blindness, including ... to the MiDROPS™ formulation platform developed by EyeCRO, which ... the eye via a topical eyedrop. , Under ...
(Date:5/4/2015)... SC (PRWEB) May 04, 2015 Ticket Down ... at the Colonial Life Arena in Columbia, South Carolina. ... the continuation of his “Out There” tour which originally kicked ... long tour is North America and the legendary performer recently ... at the Wells Fargo Arena on June 21st, in Charlottesville, ...
(Date:5/4/2015)... 2015 Pricing Healthcare announces it ... one patient receiving care at St. George Surgical Center ... must be performed by July 15th, 2015, and the patient ... up front and forego the filing of insurance claims). , ... every year, and it devastates more and more individuals and ...
Breaking Medicine News(10 mins):Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 2Health News:WWE Legend "Rowdy" Roddy Piper Teams Up with Stand for the Silent for Timely Anti-Bullying Campaign 3Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... code for a type of pancreatic cancer, called neuroendocrine or ... 20 issue of Science Express, shows that patients ... as those without them. "One of the most significant ... of rare cancer has a unique genetic code that predicts ...
... Researchers from Upstate New York institutions, including the ... two industrial pollutants in carp in eastern Lake ... demonstrating the lasting environmental effects of human activity ... The two contaminants the scientists studied were polychlorinated ...
... in an 8-week mindfulness meditation program appears to make ... of self, empathy and stress. In a study ... Psychiatry Research: Neuroimaging, a team led by ... their study, the first to document meditation-produced changes over ...
... , FRIDAY, Jan. 21 (HealthDay News) -- Americans suffering from ... in a cream to help soothe their aches. But ... on: analgesics delivered through a medicated patch placed directly where ... the country,s first over-the-counter, pain-relieving transdermal patches in 2008. But ...
... Department of Psychiatry at Case Western Reserve University School of ... National Institute of Mental Health (NIMH) for the long-term study ... the NIMH, one of the National Institutes of Health (NIH), ... in which 707 children between the ages of six and ...
... HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay News) -- ... think vaccines don,t cause autism, a new Harris Interactive/HealthDay ... vaccines, like the measles-mumps-rubella (MMR) vaccine, can cause the disorder, ... conducted last week, following news reports that said the lead ...
Cached Medicine News:Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 3Health News:Scientists find industrial pollutants in Eastern Lake Erie carp 2Health News:Scientists find industrial pollutants in Eastern Lake Erie carp 3Health News:Mindfulness meditation training changes brain structure in 8 weeks 2Health News:Mindfulness meditation training changes brain structure in 8 weeks 3Health News:Pain Patches Making Gains in U.S. 2Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 2Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 3Health News:Nearly Half of Americans Still Suspect Vaccine-Autism Link 2Health News:Nearly Half of Americans Still Suspect Vaccine-Autism Link 3
(Date:5/4/2015)... 4, 2015  Amgen (NASDAQ: AMGN ) will present ... a.m. ET on Thursday, May 7, 2015, at the InterContinental ... , executive vice president of Global Commercial Operations at Amgen, ... can be accessed from the Events Calendar on Amgen,s website, ... will also be available on Amgen,s website for 90 days ...
(Date:5/4/2015)... DALLAS , May 4, 2015   The ... new injection, Kybella, from internationally acclaimed plastic surgeon, ... Food and Drug Administration, is proven to reduce fat ... http://photos.prnewswire.com/prnh/20150504/213559 The active ingredient in ... and gives plastic surgeons the ability to reshape this ...
(Date:5/4/2015)... Mass. and TORONTO , ... www.generex.com ) (OTCQB:GNBT) today announced that it intends to ... it receives upon completion of a definitive licensing agreement ... Smoofi, Inc. ( www.smoofi.com ) (OTCQB:SMFI). As ... non-binding letter of intent in respect of the licensing ...
Breaking Medicine Technology:Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5
... 2010 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ... U.S. Food and Drug Administration (FDA) to schedule a meeting ... emulsion for injection). The FDA is expected to set the ... ADVENTRX. "We have performed an extensive analysis of ...
... Allscripts MyWay EHR version 9.0 has received ... Record (EHR) software capable of enabling providers to meet ... for funding under the American Recovery and Reinvestment Act ... Health Records Office of the National Coordinator Authorized Testing ...
Cached Medicine Technology:ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study 2ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study 3ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study 4Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 2Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 3Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 4Allscripts MyWay™ Electronic Health Record Receives ONC-ATCB Certification by Drummond Group 5
Prostate biopsy transducer....
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
... Linear high frequency ... breast and superficial ... exclusive Hemispheric Sound ... technologies. This multi-frequency ...
... an excellent choice for a ... wide scan angle. With muliple ... designed for a wide view ... versatility of this transducer provides ...
Medicine Products: